Stay updated on Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:33:01.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about the study of pembrolizumab in treating metastatic melanoma, including details on laboratory biomarker analysis and quality-of-life assessments. Additionally, the principal investigator's name has been clarified, and the revision number has been updated.
    Difference
    55%
    Check dated 2025-04-16T20:42:44.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 15, 2025.
    Difference
    0.4%
    Check dated 2025-04-09T16:06:26.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has updated its versioning information, moving from Revision v2.14.2 to v2.14.3, and has changed the date of the last update from January 15, 2025, to March 25, 2025.
    Difference
    0.3%
    Check dated 2025-04-02T00:34:26.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T23:30:39.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T18:14:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Chemo in Metastatic Melanoma Clinical Trial page.